Urine proteomic signatures of histological class, activity, chronicity, and treatment response in lupus nephritis.
Fava A, Buyon J, Magder L, Hodgin J, Rosenberg A, Demeke DS, Rao DA, Arazi A, Celia AI, Putterman C, Anolik JH, Barnas J, Dall'Era M, Wofsy D, Furie R, Kamen D, Kalunian K, James JA, Guthridge J, Atta MG, Monroy Trujillo J, Fine D, Clancy R, Belmont HM, Izmirly P, Apruzzese W, Goldman D, Berthier CC, Hoover P, Hacohen N, Raychaudhuri S, Davidson A, Diamond B; Accelerating Medicines Partnership in RA/SLE network; Petri M.
Fava A, et al. Among authors: buyon j.
JCI Insight. 2024 Jan 23;9(2):e172569. doi: 10.1172/jci.insight.172569.
JCI Insight. 2024.
PMID: 38258904
Free PMC article.